United States · Series A startup

Who invested in Macrolide Pharmaceuticals

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$22Mraised across 1 round since 2015, from 1 source

Latest round
Series A, $22MMar 2015
Investors
4
See who backed them

The rounds

  1. Mar 2015
    Series A$22M

    From a historical funding recordSEC filing: $8.2M sold, first sale Feb 2015

Everyone who backed them

Novartis Venture FundCorporate VC1round
SR OneCorporate VC1round
Roche Venture FundCorporate VC1round
Gurnet Point CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Macrolide Pharmaceuticals

Who invested in Macrolide Pharmaceuticals?

Macrolide Pharmaceuticals's investors include Novartis Venture Fund, SR One, Roche Venture Fund and Gurnet Point Capital.

How much has Macrolide Pharmaceuticals raised?

Macrolide Pharmaceuticals has raised $22M across 1 round since 2015.

When did Macrolide Pharmaceuticals last raise?

Macrolide Pharmaceuticals's most recent round was a Series A of $22M in Mar 2015.

What was Macrolide Pharmaceuticals's biggest round?

Its most recent round, $22M in Mar 2015, is also its largest on record.

Who backed Macrolide Pharmaceuticals first?

Macrolide Pharmaceuticals's first round on record, in Mar 2015, was backed by Novartis Venture Fund, SR One and Roche Venture Fund and 1 others.

What stage is Macrolide Pharmaceuticals at?

Macrolide Pharmaceuticals's latest named round is a Series A, in Mar 2015.

Where is Macrolide Pharmaceuticals based?

Macrolide Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.